Legend Biotech Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

Legend Biotech (NASDAQ: LEGN) will participate in upcoming investor conferences: Jefferies Healthcare Conference on June 7, 2023, and Goldman Sachs 44th Annual Global Healthcare Conference on June 14, 2023.

Positive

• Legend Biotech will have the opportunity to showcase its novel therapies at the investor conferences, potentially attracting new investors and increasing stock price.

Negative

• No negative takes found.

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced it will participate in the upcoming investor conferences:

Event: Jefferies Healthcare Conference
Location: New York, NY
Fireside Chat Date & Time: Wednesday, June 7, 2023 at 1:30pm ET
Presenter: Ying Huang, Ph.D., CEO

Event: Goldman Sachs 44th Annual Global Healthcare Conference
Location: Dana Point, CA
Fireside Chat Date & Time: Wednesday, June 14, 2023 at 8:00am PT
Presenter: Ying Huang, Ph.D., CEO

About Legend Biotech

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.

Learn more at www.legendbiotech.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230602005227/en/

Investor Contacts:

Joanne Choi, Senior Manager, Investor Relations, Legend Biotech

joanne.choi@legendbiotech.com

Crystal Chen, Manager, Investor Relations, Legend Biotech

crystal.chen@legendbiotech.cn

Press Contact:

Tina Carter, Corporate Communications Lead, Legend Biotech

tina.carter@legendbiotech.com

(908) 331-5025

Source: Legend Biotech

FAQ

When is the Jefferies Healthcare Conference?

The Jefferies Healthcare Conference is on June 7, 2023.

Who will be presenting at the Goldman Sachs 44th Annual Global Healthcare Conference?

Ying Huang, Ph.D., the CEO of Legend Biotech, will be presenting at the Goldman Sachs 44th Annual Global Healthcare Conference on June 14, 2023.